Psychedelic Spotlight Podcast

In this episode David Flores, CEO of Spotlight Media Corp, sits down with the founding members of the newly formed Healing REIT that will focus on investing in real estate designed for innovative medicine such as psychedelic-assisted therapy.

In this episode, Swati Sharma sits down with Jennifer Montjoy, Founder of Transpersonal Research Institute of Psychotherapeutic Psychedelics also known as TRIPP. Together, they talk about the lack of diversity in the psychedelic space and discuss how TRIPP aims to help introduce more inclusivity into it.

In this episode, Dennis Walker of the Mycopreneur Podcast sits down with Tracey Tee, a serial entrepreneur and the Founder of Moms On Mushrooms.

Welcome to an exciting episode of Spotlight Media Podcast.

In this episode, Spotlight Media CEO David Flores sits down with James Lanthier, CEO of Mindset Pharma. Mindset Pharma is a Toronto-based drug discovery company focused on creating novel and patentable psychedelic compounds for the treatment of neurological and psychiatric disorders with multiple programs moving to a clinical stage.

In this conversation, David and James discuss the great deal of work that Mindset has done to set the stage for the launch of one or more drug candidates into first in-human clinical trials in 2023.  They also discuss some of the impressive advancements that the Company has accomplished with its lead psychedelic drug candidate, MSP-1014, and Mindset's latest partnership with PharmaLa, which allowed the drug discovery company to make use of their patent-pending and highly scalable psilocybin synthesis technology.

Mindset also partnered up with Cybin in 2021 which allowed the Company to gain access to their novel delivery technologies and formulations to deliver purified and potent psychedelic molecules. All these accomplishments made by Mindset Pharma are ultimately paving the way for successful clinical advancement towards approval and commercialization of psychedelic medicines.

You can find Mindset Pharma trading on the Canadian Securities Exchange under the symbol $MSET and on the American OTC market under the symbol $MSSTF.

*To learn more about Mindset Pharma visit their website: MindsetPharma.com

In this episode, we speak with Paul Karasik, founder of The Psychedelic Institute, which is dedicated to making information and safe access available to anyone and everyone who is seeking to awaken their consciousness. He's also the principal organizer of the Awakening of Consciousness Conference, the inaugural session of which occurs on Friday, September 30th in Los Angeles.

Paul has decades of experience in the world of psychedelics. In the 1960's he was a member of the early psychedelic communities in New York and California, which included such luminaries as Timothy Leary and Ram Dass. Paul co-founded Thompson's Ranch, one of the first alternative communities in Joshua Tree, CA. He's currently working on his tenth book, "Leading the Psychedelic Revolution."

Matthew and Paul discuss The Psychedelic Institute's aspirations with the launch of the Awakening of Consciousness Conference, the differences between legalization and decriminalization, and the importance of being brave, and thinking outside the box in understanding what it takes to make the most of one's own experience of sacred plant medicines.

To learn more, visit: https://cannapsychedelic.com/

In this episode we talk with Jenalle Dion, founder of Wakeful Travel, a ceremony-companion company that works with retreat centers, psychedelic clinics, therapists, and other wakeful brands to provide tools that aid in transformation and self-exploration. She is also Head of Creative Partnerships at Third Wave and is a MAPS Canada Volunteer in Vancouver.

After studying holistic nutrition, Jenalle became obsessed with alternative healing modalities — an obsession that saw her enter the world of psychedelic plant medicine as Head of Content and Partnerships at Retreat Guru. As her relationships with both global retreat centers and sacred plants blossomed, she decided to create travel journals for adventures around the globe. When the pandemic hit, however, she pivoted from creating journals that focused on external travel to developing psychedelic and microdosing journals to support internal travel.

Jenalle talks with Spotlight about the cultivation of her journal company, Wakeful Travel, and her story of pivoting from a travel-focus to the integration space. She also discusses why journalling is so important to the psychedelic experience, how it impacts the integration process, and the benefits of writing vs. digital journalling.

To learn more visit http://www.wakefultravel.com and connect on Instagram at @wakefultravel and LinkedIn https://www.linkedin.com/company/wakeful-travel/

Alli Schaper is an entrepreneur, community builder, speaker, mental wellness advocate, and enthusiast for all things mushrooms and psychedelic medicine. She is currently the CEO & Co-Founder of Into The Multiverse, an education-first ecosystem for all things fungi with the mission to rebrand functional mushrooms and encourage collaboration amongst the psychedelics industry.

Her and her team created the world's first functional mushroom marketplace, The Multiverse (http://yourmultiverse.com/) and SuperMush (http://supermush.com/), their in-house consumer lifestyle brand. Previously, she left her career in corporate innovation and healthcare consulting to found a travel wellness company alongside an events platform focused on intentional connection.

She is also the host of Into The Multiverse (https://www.instagram.com/intothemultiverse/), a podcast for conversations with thought leaders and experts across everything from functional fungi to psychedelic medicine. Her passion for bringing microdosing psychedelics to the mainstream wellness conversation led her to collaboratively launch Microdosing Collective (http://microdosingcollective.org/), a non-profit organization dedicated to education on the benefits of legalizing microdosing psilocybin for optimal human wellness. 

In this episode, Alli speaks on functional mushrooms for health: what they are, why they’re important, and what benefits they provide. She also delves into how functional mushrooms, when combined with psychoactive mushrooms such as psilocybin, impact the body. Lastly, Alli speaks on her own line of functional mushroom products, SuperMush, and her podcast Into the Multiverse.

Christi Myers is the founder and CEO of Flow Integrative ketamine clinic, which she formed from a place of passion for the potential of psychedelic wellness.  She has over 20 years of experience as a paramedic and is formerly a professor of Emergency Medical Services.  She focused her training credentials around her vision to “help the help” and provide supportive services for front-line workers and service men and women who face chronic and complex trauma.

In regards to psychedelic therapy, she has thorough training in integrative treatment modalities of psychotherapy combined with the valuable role that ketamine and other psychedelics hold to unlock deep, successful treatment.

In this episode, Christi provides insight into how ketamine impacts people's physical and mental health. She goes into the comparison of ketamine's effects compared to other psychedelics and how Flow Integrative's patient care is unique. Finally, we get Christi's opinion on the psychedelic telemedicine model and the safety of at-home ketamine use.

Learn more about her work at https://flowintegrativeketamine.com/

Jahan Khamsehzadeh, Ph.D. completed his dissertation on psychedelics in the Philosophy, Cosmology, and Consciousness program at the California Institute of Integral Studies (CIIS) in San Francisco. His dissertation ultimately became a book titled, The Psilocybin Connection: Psychedelics, the Transformation of Consciousness, and Evolution of the Planet—An Integral Approach, and was published by North Atlantic Books and distributed by Penguin Random House.

He earned his Masters in Consciousness and Transformative Studies from John F. Kennedy University, and his Bachelors from the University of Arizona with a major in Philosophy and minors in Physics, Psychology, and Mathematics. Aside from academic work, he has undergone several major trainings, including graduating from the Hakomi somatic-psychotherapy program and training within the Mazatec mushroom tradition. He assisted the Psychedelic-Assisted Psychotherapy Certificate training at CIIS for two years, and mentored for a year at the the School of Consciousness Medicine. Currently, he works as a facilitator for legal psilocybin mushrooms ceremonies in Jamaica with Atman Retreats.

In this episode, Dr. Khamsehzadeh delves into our historical and ancestral relationship to psilocybin and theorizes how mushrooms have impacted the development of the brain. He goes on to discuss how mushroom-use gave rise to artistic and creative expression. Aside from psychedelics role in creativity and evolution, Dr. Khamsehzadeh explains how psychedelics can assist us with achieving self-transcendence through “peak experience”.

To learn more visit: www.PsychedelicEvolution.org